G. Dolan

发表

Practical considerations for nonfactor‐replacement therapies in the treatment of haemophilia with inhibitors

C. Hermans, V. Jiménez‐Yuste, G. Auerswald, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Switching treatments in haemophilia: is there a risk of inhibitor development?

V. Jiménez‐Yuste, G. Auerswald, G. Benson, 2014, European journal of haematology.

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

A. Duffy, C. Hermans, V. Jiménez‐Yuste, 2018, European journal of haematology.

Hemophilia treatment in 2021: Choosing the"optimal" treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians.

C. Königs, C. Hermans, V. Jiménez‐Yuste, 2021, Blood reviews.

Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery.

J. Plumb, G. Dolan, I. Brenkel, 2009, Clinical therapeutics.

Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations

C. Hermans, G. Dolan, K. Fischer, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Effect of age upon the induction and maintenance of anticoagulation with warfarin.

J. Gladman, G. Dolan, 1995, Postgraduate medical journal.

Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey

G. Dolan, C. Altisent, J. Windyga, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization

G. Dolan, M. Laffan, K. Pasi, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood

Andrew J. Johnson, G. Dolan, M. Behan, 2005, Platelets.

A framework for genetic service provision for haemophilia and other inherited bleeding disorders

D. Perry, A. Fryer, G. Dolan, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical implications of emerging pathogens in haemophilia: the variant Creutzfeldt–Jakob disease experience

G. Dolan, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement

A. Iorio, E. Iserman, J. Oldenburg, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.

A. Duffy, C. Hermans, G. Auerswald, 2018, Blood transfusion = Trasfusione del sangue.

Challenges and controversies in haemophilia care in adulthood

R. Madhok, U. Spengler, C. Hermans, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Tyr346→Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype – is this mild haemophilia A?

G. Dolan, M. Hill, J. Westby, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Haemophilia in a real‐world setting: the value of clinical experience in data collection

A. Iorio, G. Dolan, R. Lassila, 2016, European journal of haematology.

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations

C. Hermans, G. Dolan, H. Chambost, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacement

J. Plumb, G. Dolan, I. Brenkel, 2009, Thrombosis and Haemostasis.

Use of the UKHCDO Database for a postmarketing surveillance study of different doses of recombinant factor VIIa in haemophilia

G. Dolan, C. Hay, C. Hay, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Haemophilia B: Where are we now and what does the future hold?

A. Duffy, C. Hermans, V. Jiménez‐Yuste, 2017, Blood reviews.

Pfizer‐sponsored satellite symposium at the European Haemophilia Consortium (EHC) congress. Understanding health outcomes: focus on haemophilia

G. Dolan, C. Martinoli, B. O’Mahony, 2013, European journal of haematology. Supplementum.

FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations

D. Perry, G. Dolan, M. Laffan, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

European retrospective study of real‐life haemophilia treatment

J. Oldenburg, C. Hermans, G. Dolan, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Managing Haemophilia for Life: 4th Haemophilia Global Summit

J. Astermark, V. Jiménez‐Yuste, G. Dolan, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data

C. Hermans, G. Dolan, C. Rothschild, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?

C. Hermans, G. Dolan, E. Santagostino, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Outcome measures for adult and pediatric hemophilia patients with inhibitors

A. Duffy, C. Hermans, V. Jiménez‐Yuste, 2017, European journal of haematology.

Managing Haemophilia for Life: 5th Haemophilia Global Summit

C. Hermans, V. Jiménez‐Yuste, G. Dolan, 2015, European journal of haematology.

A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients

C. Leissinger, G. Dolan, T. Lambert, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

European Study on Orthopaedic Status of haemophilia patients with inhibitors

G. Dolan, M. Morfini, S. Haya, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

ESOS: a European study on the orthopaedic status of patients with haemophilia and inhibitors

G. Dolan, 2005, Haemophilia.

Principles of care for acquired hemophilia

C. Hermans, V. Jiménez‐Yuste, G. Benson, 2021, European journal of haematology.

Multidisciplinary Team Care of Patients with Hemophilic Arthropathy: A Qualitative Assessment of Contemporary Practice in the UK and Canada

G. Dolan, J. Teitel, P. Chowdary, 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Value of prophylaxis vs on‐demand treatment: Application of a value framework in hemophilia

G. Dolan, D. Nugent, B. O’Mahony, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.

A. Duffy, C. Hermans, V. Jiménez‐Yuste, 2017, Blood transfusion = Trasfusione del sangue.

Atrial fibrillation in patients with haemophilia: a cross‐sectional evaluation in Europe

G. Dolan, R. Klamroth, R. Schutgens, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Achieving the unimaginable: Health equity in haemophilia

G. Dolan, M. Skinner, E. Berntorp, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Advances in Hemophilia Care: Report of Two Symposia at the Hemophilia 2010 World Congress

E. Steinhagen-Thiessen, C. Hermans, G. Dolan, 2012, Advances in Therapy.

Practical aspects of extended half-life products for the treatment of haemophilia

C. Hermans, V. Jiménez‐Yuste, G. Benson, 2018, Therapeutic advances in hematology.

Partnering to change the world for people with haemophilia: 6th Haemophilia Global Summit, Prague, Czech Republic, 24–26th September 2015

J. Astermark, J. Blatny, C. Hermans, 2016, European journal of haematology.

Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities—a practical review

C. Hermans, G. Dolan, 2020, Therapeutic advances in hematology.

Haemophilia care then, now and in the future

J. Oldenburg, G. Dolan, G. Lemm, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Pain and pain management in haemophilia

A. Duffy, C. Hermans, V. Jiménez‐Yuste, 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey

G. Dolan, C. Altisent, J. Windyga, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation

G. Dolan, M. Scott, H. Xiang, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinical phenotype

G. Dolan, M. Hill, S. Deam, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

Partnering to change the world for people with haemophilia: 7th Haemophilia Global Summit, Madrid, Spain 22–24 September 2016

G. Dolan, 2017, European journal of haematology.

Neonatal bleeding in haemophilia: a European cohort study

C. Combescure, G. Dolan, T. Lambert, 2012, British journal of haematology.

The challenge of an ageing haemophilic population

G. Dolan, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Management of atrial fibrillation in people with haemophilia – a consensus view by the ADVANCE Working Group

G. Dolan, R. Klamroth, R. Schutgens, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical management of older persons with haemophilia.

C. Hermans, G. Dolan, P. Moerloose, 2014, Critical reviews in oncology/hematology.

Preliminary Observations from the European Study on Orthopedic Status (ESOS) in Hemophilia Patients with Inhibitors.

G. Dolan, M. Morfini, S. Haya, 2006 .

Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia – an assessment by the ADVANCE Working Group

G. Dolan, R. Schutgens, P. Moerloose, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Enhancing haemophilia care through registries

G. Dolan, M. Makris, M Makris, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

UK Haemophilia Centre Doctors’ Organisation guidance on the use of extended‐half‐life coagulation factor concentrates in routine clinical practice: Report of a meeting on their adoption by Belgian haemophilia treaters

C. Hermans, G. Dolan, K. Peerlinck, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

A preliminary application of a haemophilia value framework to emerging therapies in haemophilia

G. Dolan, H. Eichler, B. O’Mahony, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Management of Acute Haemarthrosis in Haemophilia: a European Survey

G. Dolan, R. Hermans, K. Fischer, 2009 .

Gene therapy trials in the UK: is haemophilia a suitable 'model'?

D. Perry, G. Dolan, K. Pasi, 2004, Clinical medicine.

Vigam‐S, a solvent/detergent‐treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura

G. Dolan, J. Cavenagh, A. Newland, 2001, Transfusion medicine.

Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias

G. Dolan, M. Hill, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Viral interference in haemophilia

G. Dolan, 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders.

G. Dolan, M. Powell, Zoe E Schaedel, 2005, American journal of obstetrics and gynecology.

Whole exome sequencing identifies a mutation in thrombomodulin as the genetic cause of a suspected platelet disorder in a family with normal platelet function

S. Watson, G. Dolan, N. Morgan, 2017, Platelets.

Coeliac axis thrombosis associated with the combined oral contraceptive pill: a rare cause of an acute abdomen

G. Dolan, G. Arul, C. Rance, 1998, Pediatric Surgery International.

Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature.

G. Dolan, J. Plumb, S. Collins, 2008, Current Medical Research and Opinion.

Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature

J. Plumb, G. Dolan, S. Collins, 2008 .

Genetic analysis in FXI deficiency: six novel mutations and the use of a polymerase chain reaction‐based test to define a whole gene deletion

G. Dolan, M. Hill, H. Franks, 2005, British journal of haematology.

The rare coagulation disorders – review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation

D. Perry, G. Dolan, A. Mumford, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Management of acute bleeding in a patient with congenital afibrinogenaemia

G. Dolan, V. Perifanis, M. Hill, 2006, Haemophilia.

Changing patterns of bleeding in patients with severe haemophilia A

G. Dolan, D. Stephensen, G. Dolan, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Short communication: Pregnancy outcome in Factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with Factor XI deficiency

G. Dolan, S. Pavord, G. Dolan, 2007, BJOG : an international journal of obstetrics and gynaecology.

Lack of response to thalidomide in plasmacytomas

G. Dolan, G. Dolan, B. Myers, 2001, British journal of haematology.

Prevalence of COVID‐19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe

J. Astermark, C. Hermans, G. Dolan, 2023, Haemophilia : the official journal of the World Federation of Hemophilia.

Enhancing haemophilia care through registries

G. Dolan, M. Makris, J. Rowell, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical management of older persons with haemophilia.

C. Hermans, G. Dolan, P. Moerloose, 2014, Critical reviews in oncology/hematology.